Inhibikase Therapeutics Inc (IKT) — Net Asset Quality Index
Inhibikase Therapeutics Inc (IKT) has a Net Asset Quality Index of 91.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $79.59 Million minus total liabilities of $6.70 Million yields net assets of $72.90 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore cash flow to debt ratio of Inhibikase Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Inhibikase Therapeutics Inc Net Asset Quality Index Over Time (2016–2024)
This chart shows how Inhibikase Therapeutics Inc's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 91.6%, representing net assets of $72.90 Million against total assets of $79.59 Million USD. See Inhibikase Therapeutics Inc shareholders equity for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Inhibikase Therapeutics Inc (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Inhibikase Therapeutics Inc from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Inhibikase Therapeutics Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 96.2% | $94.87 Million | $98.60 Million | $3.73 Million | ▲ +20.5 pp |
| 2023 | 75.7% | $10.98 Million | $14.51 Million | $3.53 Million | ▼ -8.7 pp |
| 2022 | 84.4% | $21.04 Million | $24.94 Million | $3.90 Million | ▼ -6.1 pp |
| 2021 | 90.5% | $38.42 Million | $42.47 Million | $4.05 Million | ▲ +24.3 pp |
| 2020 | 66.2% | $9.78 Million | $14.78 Million | $5.00 Million | ▲ +11803.6 pp |
| 2019 | -11737.4% | $-4.49 Million | $38.25K | $4.53 Million | ▼ -11710.0 pp |
| 2018 | -27.3% | $-777.97K | $2.85 Million | $3.62 Million | ▲ +478.0 pp |
| 2017 | -505.3% | $-1.44 Million | $285.17K | $1.73 Million | ▲ +324.3 pp |
| 2016 | -829.6% | $-1.35 Million | $162.93K | $1.51 Million | — |